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Voiding Dysfunction
Effects of Obesity on Prostate Volume and Lower Urinary Tract 
Symptoms in Korean Men
Geun Woo Kim, Seung Whan Doo, Won Jae Yang, Yun Seob Song
Department of Urology, Soonchunhyang University College of Medicine, Seoul, Korea
Purpose: We investigated the effects of obesity on prostate volume (PV) and lower uri-
nary tract symptoms (LUTS) in Korean men.
Materials and Methods: From December 2007 to 2009, a total of 10,383 ostensibly 
healthy Korean men aged ≥50 years visited our health promotion center for a routine 
check-up. Among them, 872 men who wanted a prostate evaluation were enrolled in 
this study. All men underwent detailed clinical evaluations with the International 
Prostate Symptom Score (IPSS) questionnaire. Anthropometric measurements, in-
cluding height, weight, and waist and hip circumferences, were determined. A blood 
sample was obtained for serum prostate-specific antigen (PSA) measurement. 
Thereafter, a digital rectal examination and transrectal ultrasound were performed. 
Results: In total, 465 men with moderate to severe LUTS (IPSS≥8 points) were in-
cluded in this prospective study. The participants’ mean age was 57.2 years. 
Multivariate analysis demonstrated that only waist circumference was a significant 
factor in predicting PV besides age and serum PSA. The univariate analysis showed 
no statistically significant relations between any of the obesity-related parameters and 
LUTS. The PV was also not correlated with LUTS. 
Conclusions: Central obesity is the more important predictor of PV than overall obesity. 
There are no significant relations between obesity-related parameters and LUTS.
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INTRODUCTION
Lower urinary tract symptoms (LUTS), often the result of 
benign prostatic hyperplasia (BPH), are common among 
older men and have a negative impact on their quality of 
life [1]. Multiple studies have reported that obese men have 
a larger prostate volume (PV) than do nonobese men [2-6], 
and recently some studies have revealed that a relation-
ship exists between obesity and LUTS [2,4,7,8]. The sug-
gested pathophysiology was hyperinsulinemia [9-11], 
caused by tissue insulin resistance, which stimulates the 
autonomic nervous system, particularly the sympathetic 
nervous system [12]. The overactivity of the sympathetic 
nervous system results in bladder outlet obstruction and 
LUTS. 
　The Korean National Health and Nutrition Surveys re-
ported an increase in the prevalence of obesity from 1995 
to 2001 [13]. The prevalence of clinical BPH was reported 
to be from 10.6% to 31% in men over 50 years of age, with 
an age-related increase seen in South Korea [14,15]. 
However, there are insufficient data on the effect of obesity 
on LUTS in Korean men. Therefore, in this cross-sectional 
study, we investigated the effects of obesity on PV and 
LUTS in Korean men.
MATERIALS AND METHODS
From December 2007 to 2009, a total of 10,383 ostensibly 
healthy Korean men aged ≥50 years visited our health pro-
motion center for a routine check-up. Among them, 872 
men who wanted a prostate evaluation were enrolled in 
this study.
　All men underwent detailed clinical evaluations with the 
International Prostate Symptom Score (IPSS) questio-
nnaire. Anthropometric measurements, including height, 
weight, and waist and hip circumferences, were deter-
mined. A blood sample was obtained for serum prostate- 
specific antigen (PSA) measurement (AxSYM, Abbott Korean J Urol 2010;51:344-347
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TABLE 2. Univariate correlation analysis between various parameters
Variables PV PSA Storage Voiding IPSS WHR WC BMI
Age r
p
0.150
0.001
0.135
0.003
0.230
＜0.001
0.071
0.131
0.164
＜0.001
0.077
0.101
0.019
0.691
0.047
0.316
BMI r
p
0.164
＜0.001
0.042
0.371
0.020
0.660
0.030
0.520
0.033
0.480
0.497
＜0.001
0.754
＜0.001
WC r
p
0.217
＜0.001
0.070
0.135
0.016
0.726
0.043
0.350
0.041
0.377
0.802
＜0.001
WHR r
p
0.174
＜0.001
0.058
0.212
0.061
0.194
0.010
0.835
0.037
0.431
IPSS r
p
0.027
0.560
0.033
0.485
0.673
＜0.001
0.884
＜0.001
  Voiding r
p
0.012
0.801
0.022
0.633
0.251
＜0.001
  Storage r
p
0.076
0.106
0.033
0.487
PSA r
p
0.151
0.001
PV: prostate volume, PSA: prostate-specific antigen, IPSS: International Prostate Symptom Score, WHR: waist to hip ratio, WC: waist 
circumference, BMI: body mass index, r: correlation coefficient, p: as determined by Pearson’s correlation coefficient
TABLE 1. Characteristics of the study population
Characteristics Mean±SD
Age (years) 57.2±5.6
BMI (kg/m
2) 24.64±2.64
WC (cm) 83.6±7.1
WHR 0.90±0.05
IPSS 13.8±5.1
  Voiding 8.9±3.9
  Storage 4.9±2.5
PV (ml) 26.6±8.6
PSA (ng/ml) 1.50±0.70
BMI: body mass index, WC: waist circumference, WHR: waist to 
hip ratio, IPSS: International Prostate Symptom Score, PV: pros-
tate volume, PSA: prostate-specific antigen
TABLE 3. Multiple linear regression analysis to determine 
independent predictors of PV
Variables Coefficient p-value VIF
Age
BMI
WC
PSA
0.153
0.027
0.183
0.142
0.001
0.696
0.008
0.002
1.011
2.338
2.342
1.007
PV: prostate volume, VIF: variation inflation factor, BMI: body 
mass index, WC: waist circumference, PSA: prostate-specific an-
tigen
Laboratories, Abbott Park, IL, USA). Thereafter, a digital 
rectal examination (DRE) and transrectal ultrasound was 
performed. Body mass index (BMI) was calculated as the 
weight divided by square of the height, and waist-to-hip ra-
tio (WHR) was determined as the waist circumference div-
ided by the hip circumference.
　The exclusion criteria of this study were mild LUTS 
(IPSS＜8); the use of medications affecting prostate growth, 
such as antiandrogens and 5-α-reductase inhibitors; a high 
serum PSA level of ＞4.0 ng/ml; abnormal findings on the 
DRE; pyuria (white blood cells ＞5 on urinalysis), the pres-
ence of neurogenic bladder dysfunction; confirmed pros-
tate cancer; acute or chronic urinary retention status; 
acute or chronic prostatitis within the previous 3 months; 
a history of recurrent urinary tract infection or bladder 
stones; and previous surgical intervention related to BPH. 
　Univariate analysis by Pearson’s correlation coefficient 
was used to test the linearity of the relationships among 
the variables. Multiple linear regression analysis was used 
to test the linear effect of variables in predicting PV. All 
statistical analysis was performed by using commercially 
available software (SPSS, version 14.0 KO, Chicago, IL, 
USA). A p-value of ＜0.05 was considered statistically 
significant. 
RESULTS
In total, 465 men with LUTS (IPSS≥8 points) and aged ≥
50 years were included in this prospective study. The par-
ticipants’ mean age was 57.2 years (Table 1). 
　The univariate analysis showed that the PV was pos-
itively correlated with all obesity-related parameters: 
BMI, waist circumference, and WHR (Table 2). However, 
multiple linear regression analysis demonstrated that, 
among the obesity-related parameters, only waist circum-
ference was a significant factor in predicting PV (Table 3). 
　We then examined the correlation between obesity pa-
rameters and LUTS represented by IPSS. The univariate 
analysis showed that there were no statistically significant 
relationships between obesity-related parameters and Korean J Urol 2010;51:344-347
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LUTS (Table 2). Voiding and storage symptoms also re-
vealed no correlation with any obesity-related parameters. 
PV was not correlated with any type of LUTS. 
DISCUSSION
LUTS comprise a spectrum of voiding and storage symp-
toms, which in men are generally considered a sign of clin-
ically significant BPH [16]. A review of the available data 
appears to support a strong independent relationship be-
tween obesity and BPH or LUTS.
　Over the past two decades, many different groups have 
investigated the influence of obesity on the development of 
BPH and LUTS with conflicting results [1,17-22]. Most of 
these groups have concluded that overall obesity, abdomi-
nal obesity, and/or WHR can increase the risk of BPH and 
LUTS, at least to some degree. 
　The Veterans Administration Normative Aging Study 
reported that increased BMI was a significant predictor of 
a clinical diagnosis of BPH [17]. Rohrmann et al examined 
the association between obesity and LUTS in the National 
Health and Nutrition Examination Survey (NHANES) III 
cohort [1]. They found that an increase in BMI after age 25 
was positively associated with LUTS. They also noted that 
men with a larger waist circumference (＞102 cm) were 
more likely to have LUTS than were men with a smaller 
waist circumference. Kristal et al examined several modifi-
able lifestyle factors related to the development of sympto-
matic BPH in 5,600 men enrolled in the placebo arm of the 
Prostate Cancer Prevention Trial who were followed for 7 
years [18]. They reported significant increases in sympto-
matic BPH (IPSS＞14), with abdominal obesity as meas-
ured by WHR. Laven et al examined a cohort of 27,858 
Swedish men and found that low birth weight and abdomi-
nal obesity, but not BMI, were associated with an increased 
risk of LUTS [19]. Together, these results suggested that 
weight gain and central adiposity in adulthood were asso-
ciated with a higher prevalence of LUTS. 
　However, these results may not be universally applicable. 
Joseph et al looked at modifiable risk factors for LUTS spe-
cifically in black men and found no greater risk with in-
creasing BMI [10]. Gupta et al followed 1206 Vietnam vet-
erans from the Air Force Health Study for an average peri-
od of 15 years and showed no increased risk of BPH or LUTS 
in men with metabolic syndrome compared with that in 
men without it [3]. 
　To our knowledge, only three studies have assessed the 
relationship between obesity and LUTS in Korean men 
[20-22], and all were done in a cross-sectional manner. One 
was a community-based study performed in 348 elderly 
men whose age was over 65 years, in which no relationship 
between obesity and LUTS was shown [20]. The second 
study also showed that there was no association between 
metabolic syndrome and voiding dysfunction in men older 
than in their 60 s [21]. The third study by Lee et al involving 
602 patients (aged ≥40 years) with BPH or LUTS who were 
attending a urology clinic, provided evidence that central 
obesity is the predictor of LUTS correlated with BPH [22]. 
That study reported that Korean men with a waist circum-
ference of ＞90 cm experienced a 1.36-fold increased risk 
of severe LUTS compared with those with a waist circum-
ference of ≤90 cm. They also observed that storage symp-
toms, such as nocturia and urgency, increased with in-
creasing PV in men with a waist circumference of ＞90 cm 
[22].
　Our study of 465 men recruited through the health pro-
motion center showed that PV was positively correlated 
with central obesity, as represented by waist circum-
ference, but not with BMI, which represented overall 
obesity. There was no significant relationship between obe-
sity-related parameters and LUTS. Our study might have 
been affected by selection bias due to the heterogeneous eli-
gibility of the study population. This may be why our study 
population showed a relatively small PV (mean: 26.6 ml) 
compared with the PV values reported in the three studies 
mentioned above [20-22]. 
　Recent studies concerning the pathophysiology of BPH 
have suggested that in addition to the conventional risk 
factors, such as age, family history, and androgen activity, 
newly identified risk factors, such as diet and obesity, may 
have a major role in the development of BPH [23]. However, 
most of theses studies were performed in Western persons. 
We think it may be difficult to directly adopt the results of 
those studies to Korean persons, because differences in the 
incidence of BPH, LUTS, and obesity exist among different 
ethnic groups. Moreover, obesity defined by the Adult 
Treatment Panel III is much more rigid for Western men 
(＞102 cm of waist circumference) than for Orientals (＞90 
cm of waist circumference). 
　We need another large, longitudinal, prospective, com-
munity-based study to fully reveal the relationship be-
tween obesity and BPH or LUTS in Korean men. 
CONCLUSIONS
Our data showed that PV was positively correlated with 
central obesity, as represented by waist circumference, but 
not with BMI, which represented overall obesity. There 
was no significant relationship between obesity-related 
parameters and LUTS. 
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